Piramal Phytocare has informed that in reference to the letter dated 4th November, 2019 it had enclosed the Unaudited Financial Results for the quarter and half year ended 30th September, 2019 together with the Limited Review Report by the Auditors. In the Statement of Assets and Liabilities as on 30th September, 2019, the figures for the half year ended 30th September, 2019 were inadvertently mentioned as audited instead of unaudited. In this regard, it has enclosed the Revised Unaudited Financial Results for the quarter and half year ended 30th September, 2019; and Limited Review Report by the Auditors.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1665.25 |
| Dr. Reddys Lab | 1220.75 |
| Cipla | 1232.90 |
| Zydus Lifesciences | 928.85 |
| Lupin | 2311.75 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: